Business Services Industry
Fitch Affirms Advanta At 'B+' & Revises Outlook to Positive
Business Wire, July 21, 2004
NEW YORK -- Fitch Ratings has revised the Rating Outlook on Advanta Corp. (Advanta) to Positive from Stable and affirmed the long-term rating of 'B '. In conjunction with this action, Fitch has assigned new ratings to Advanta Bank Corp. (ABC) and has affirmed and withdrawn ratings on Advanta National Bank (ANB). A detailed list of affected ratings is available at the end of this release.
Today's affirmation and Outlook revision recognize the improvement in Advanta's core operating performance, which if sustained, could result in a future upgrade of the company's ratings. Since refocusing the company on small business credit card lending, Advanta has been able to achieve stable and improving core operating results (excluding one-time charges). This improvement can be attributed to Advanta's conscious effort to target more creditworthy customers, which has resulted in lower credit losses on both a coincident and lagged basis. Fitch also views Advanta's capital levels as solid at the current rating level with an expectation that the company will maintain sound risk-adjusted capitalization. While Advanta has established a solid niche in small business credit card lending, Fitch does expect the competitive environment will become more intense in this business segment. Advanta's ability to maintain its business focus and further improve its financial profile will be partly determined by its ability to appropriately adjust to the changes in the competitive environment.
Fitch remains concerned with Advanta's outstanding litigation with J.P. Morgan Chase surrounding the sale Advanta's mortgage business in February 2001. While the outcome of this lawsuit remains uncertain, Fitch believes that even an adverse outcome would be manageable from both a capital and liquidity perspective within the current ratings.
Fitch is encouraged that Advanta has taken steps to improve the structure of its corporate governance framework. Changes such as adopting new charters for board level committees and comprising audit, compensation and nominating committees solely of independent directors move Advanta toward establishing standards that are more consistent with industry norms. While corporate governance is not currently viewed as a restraint on Advanta's ratings or preventing consideration of an upgrade, Fitch would expect to see additional enhancements in corporate governance structure and evidence that the framework produces functionality that provides benefits to its stakeholders before more meaningful changes in ratings would be considered.
Ratings affirmed with Positive Outlook
Advanta Corp.
-- Senior debt 'B ';
-- Short-term 'B'.
Advanta Capital Trust I
-- Trust preferred stock 'B-'.
Ratings assigned with Positive Outlook
Advanta Bank Corp.
-- Long-term deposits 'BB-';
-- Senior debt 'B ';
-- Short-term 'B'.
Ratings affirmed and withdrawn
Advanta National Bank
-- Long-term deposits 'BB-';
-- Senior debt 'B ';
-- Subordinated debt 'B';
-- Short-term 'B'.
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


